Use of a Biological Mesh (StratticeTM) for the Prevention of Parastomal Hernia After Colorectal Surgery With Colostomy
PROBIOCOL
Prospective, Multicenter, Randomized, Parallel Group Clinical Study Evaluating the Efficacy of a Biological Mesh (StratticeTM) for the Prevention of Parastomal Hernia After Colorectal Surgery With Colostomy
2 other identifiers
interventional
80
1 country
7
Brief Summary
In France around 5,000 colostomies are performed after elective or emergency surgery. These colostomies could be associated with major outcomes including parastomal hernia (4 - 53%) of cases. To reduce the incidence of these outcomes, several methods have been proposed but the more pertinent consist in the use of a biological mesh during the stoma's conception. Nevertheless there is no data on the use of a biological mesh (StratticeTM) for the prevention of parastomal hernia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2014
Longer than P75 for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 14, 2014
CompletedFirst Submitted
Initial submission to the registry
April 22, 2014
CompletedFirst Posted
Study publicly available on registry
April 23, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedMarch 13, 2023
March 1, 2023
4.6 years
April 22, 2014
March 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
rate of parastomal hernia
the presence of a parastomal hernia will be diagnosed either by the clinical examination either by a CT scan
postoperative month 6
Secondary Outcomes (4)
evaluation of the pain
2 years after the surgery
the postoperative morbidity
postoperative month 1
the parastomal hernia rate
postoperative year 1
the quality of life
2 years after the surgery
Study Arms (2)
Strattice
EXPERIMENTALa strattice (10 x 10) will be used during the surgery, prior to the colostomy's conception
No strattice
PLACEBO COMPARATORthe colostomy is not reinforced with a mesh
Interventions
Eligibility Criteria
You may qualify if:
- Patient requiring a colorectal surgery with a terminal colostomy
- Elective or emergency surgery
You may not qualify if:
- Has collagen-vascular, connective tissue, or uncorrectable bleeding disorders as determined clinically by the PI.
- Has any disease, including uncontrolled diabetes, which is clinically known to impact wound healing ability.
- Has an autoimmune disease, an immune deficiency, or is on immune suppression drugs
- Is pregnant, or lactating.
- Allergic to any porcine or collagen products.
- survival \< 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre Hospitalier Universitaire, Amienslead
- LifeCellcollaborator
Study Sites (7)
Amiens Universitary Hospital
Amiens, France
Amiens university hospital
Amiens, France
Beauvais hospital
Beauvais, France
Caen hospital
Caen, France
Claude Huriet Hospital
Lille, France
Lariboisiere Hospital
Paris, France
Charles Nicolle Hospital
Rouen, France
Related Publications (3)
Timmermans L, Deerenberg EB, Lamme B, Jeekel J, Lange JF. Parastomal hernia is an independent risk factor for incisional hernia in patients with end colostomy. Surgery. 2014 Jan;155(1):178-83. doi: 10.1016/j.surg.2013.06.014. Epub 2013 Nov 12.
PMID: 24238119BACKGROUNDLee L, Saleem A, Landry T, Latimer E, Chaudhury P, Feldman LS. Cost effectiveness of mesh prophylaxis to prevent parastomal hernia in patients undergoing permanent colostomy for rectal cancer. J Am Coll Surg. 2014 Jan;218(1):82-91. doi: 10.1016/j.jamcollsurg.2013.09.015. Epub 2013 Sep 29.
PMID: 24210147BACKGROUNDSwann JM, Turek FW. Transfer from long to short days reduces the frequency of pulsatile luteinizing hormone release in intact but not in castrated male golden hamsters. Neuroendocrinology. 1988 Apr;47(4):343-9. doi: 10.1159/000124935.
PMID: 3374759BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
jean marc regimbeau, MD, PhD
CHU Amiens
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 22, 2014
First Posted
April 23, 2014
Study Start
April 14, 2014
Primary Completion
December 1, 2018
Study Completion
December 1, 2023
Last Updated
March 13, 2023
Record last verified: 2023-03